Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

Recruiting

Phase 2

Artesunate OintmentArtesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

Sponsor:

Frantz Viral Therapeutics, LLC

Code:

NCT06206564

Conditions

Anal High-grade Squamous Intraepithelial Lesion

Anal HSIL

Anal HPV Infection

AIN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Artesunate ointment

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-04. This information was provided to ClinicalTrials.gov by Frantz Viral Therapeutics, LLC on 2025-05-18.